{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:40:43Z","timestamp":1788234043279,"version":"build-2803163510"},"reference-count":123,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACyT), Mexico","doi-asserted-by":"publisher","award":["762904"],"award-info":[{"award-number":["762904"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is now considered the most common chronic liver disease worldwide. NAFLD is related to changes in lipid metabolism and is characterized by the increase or accumulation of fat in hepatocytes that may progress to non-alcoholic steatohepatitis (NASH), which leads to the appearance of inflammatory processes. Treatment consists of changes in diet, physical activity, and weight control; however, these disorders represent a health problem and require the development of novel alternatives to treatment and prevention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Review and Conclusion:<\/jats:title><jats:p>NAFLD\/NASH are strongly associated with other disorders, such as metabolic syndrome (MetS); in fact, NAFLD is considered the hepatic manifestation of MetS. These disorders are related to other components of MetS, including dyslipidemia, which is characterized by an imbalance in blood cholesterol and triglyceride levels. Prebiotics and probiotics have beneficial effects on treating and preventing several ailments, including liver diseases. Specifically, in dyslipidemia, NAFLD, and NASH, probiotics play a fundamental role in conducting the biotransformation of primary bile acids into secondary bile acids, which generally have important activity as immunomodulators and metabolism regulators. The mechanisms of action of pre and probiotics involve the activity of bile acid receptors, such as FXR and TGR-5, and the events resulting from their activation. Therefore, prebiotics and probiotics may be reasonable options to prevent and treat metabolic-related liver diseases<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389201023666220818145350","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T12:01:51Z","timestamp":1660910511000},"page":"633-646","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prebiotics and Probiotics: Effects on Dyslipidemia and NAFLD\/NASH and the Associated Mechanisms of Action"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3280-1323","authenticated-orcid":true,"given":"Eduardo","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"first","affiliation":[{"name":"Laboratory of Medicinal Chemistry and Pharmacology, Centro de Investigaci\u00f3n en Biolog\u00eda de la Reproducci\u00f3n, \u00c1rea Acad\u00e9mica de Medicina, Instituto de Ciencias de la Salud, Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca Hidalgo, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-3474","authenticated-orcid":true,"given":"Alicia","family":"Rodr\u00edguez-Past\u00e9n","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry and Pharmacology, Centro de Investigaci\u00f3n en Biolog\u00eda de la Reproducci\u00f3n, \u00c1rea Acad\u00e9mica de Medicina, Instituto de Ciencias de la Salud, Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca Hidalgo, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-6267","authenticated-orcid":true,"given":"Nury","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Medicina y Homeopat\u00eda, Instituto Polit\u00e9cnico Nacional, Inicio, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-7295","authenticated-orcid":true,"given":"Luis E.","family":"Soria-Jasso","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry and Pharmacology, Centro de Investigaci\u00f3n en Biolog\u00eda de la Reproducci\u00f3n, \u00c1rea Acad\u00e9mica de Medicina, Instituto de Ciencias de la Salud, Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca Hidalgo, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-3534","authenticated-orcid":true,"given":"Raquel","family":"Cari\u00f1o-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry and Pharmacology, Centro de Investigaci\u00f3n en Biolog\u00eda de la Reproducci\u00f3n, \u00c1rea Acad\u00e9mica de Medicina, Instituto de Ciencias de la Salud, Universidad Aut\u00f3noma del Estado de Hidalgo, Pachuca Hidalgo, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.rgmx.2018.11.007","volume":"84","author":"Bernal R.R.","year":"2019","unstructured":"Bernal R.R.; Castro N.G.; Mal&#xE9; V.R.; Carmona-S&#xE1;nchez R.; Gonz&#xE1;lez M.S.; Garc&#xED;a J.I.; Ch&#xE1;vez T.N.; Aguilar S.C.; Aiza H.I.; Ballesteros M.A.; Bosques P.F.; Castillo B.M.; Ch&#xE1;vez J.A.; Cisneros G.L.; Flores C.J.; Garc&#xED;a C.D.; Guti&#xE9;rrez G.Y.; Higuera de la Tijera M.F.; Kershenobich S.D.; Ladr&#xF3;n CL.; Lizardi C.J.; L&#xF3;pez J.A.; M&#xE1;rt&#xED;nez VS.; M&#xE1;rquez G.E.; M&#xE9;ndez S.N.; Moreno AR.; Poo J.L.; Ramos M.P.; Rodr&#xED;guez H.H.; S&#xE1;nchez J.F.; Stoopen R.M.; Torre D.A.; Torres V.G.; Trejo E.R.; Uribe E.M.; Velarde J.A.; The Mexican consensus on nonalcoholic fatty liver disease. J Gastroenterol Mex 2019,84(1),69-99","journal-title":"J Gastroenterol Mex"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3904\/kjim.2017.343","volume":"33","author":"Kwak M.S.","year":"2018","unstructured":"Kwak M.S.; Kim D.; Non alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. Korean J Intern Med 2018,33(1),64-74","journal-title":"Korean J Intern Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","volume":"15","author":"Fraile J.M.","year":"2021","unstructured":"Fraile J.M.; Palliyil S.; Barelle C.; Porter A.J.; Kovaleva M.; Nonalcoholic steatohepatitis (NASH) - A review of a crowded clinical landscape, driven by a complex disease. Drug Des Devel Ther 2021,15,3997-4009","journal-title":"Drug Des Devel Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111S","author":"Mantovani A.","year":"2020","unstructured":"Mantovani A.; Scorletti E.; Mosca A.; Alisi A.; Byrne C.D.; Targher G.; Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 2020,111S,154170","journal-title":"Metabolism"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"Byrne C.D.","year":"2015","unstructured":"Byrne C.D.; Targher G.; NAFLD: A multisystem disease. J Hepatol 2015,62(1),S47-S64","journal-title":"J Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","volume":"158","author":"Aron W.J.","year":"2020","unstructured":"Aron W.J.; Warmbrunn M.V.; Nieuwdorp M.; Cl&#xE9;ment K.; Nonalcoholic fatty liver disease: Modulating gut microbiota to improve severity? Gastroenterology 2020,158(7),1881-1898","journal-title":"Gastroenterology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12944-020-01204-y","volume":"19","author":"Hedayatnia M.","year":"2020","unstructured":"Hedayatnia M.; Asadi Z.; Zare F.R.; Yaghooti K.M.; Ghazizadeh H.; Ghaffarian Z.R.; Nosrati T.A.; Mohammadi B.M.; Rohban M.; Sadabadi F.; Rahimi H.R.; Ghalandari M.; Ghaffari M.S.; Yousefi A.; Pouresmaeili E.; Besharatlou M.R.; Moohebati M.; Ferns G.A.; Esmaily H.; Ghayour-Mobarhan M.; Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis 2020,19(1),42","journal-title":"Lipids Health Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e12986","DOI":"10.1111\/jfbc.12986","volume":"43","author":"Fern&#xE1;ndez M.E.","year":"2019","unstructured":"Fern&#xE1;ndez M.E.; Lira I.G.; Cari&#xF1;o R.; Soria L.E.; P&#xE9;rez E.; P&#xE9;rez N.; Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats. J Food Biochem 2019,43(9),e12986","journal-title":"J Food Biochem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gastrohep.2017.07.006","volume":"41","author":"Ampuero J.","year":"2018","unstructured":"Ampuero J.; S&#xE1;nchez T.Y.; Aguilera V.; Bellido F.; Romero G.M.; New therapeutic perspectives in non-alcoholic steatohepatitis. Gastroenterol Hepatol 2018,41(2),128-142","journal-title":"Gastroenterol Hepatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028","volume":"17","author":"Quigley E.M.M.","year":"2019","unstructured":"Quigley E.M.M.; Prebiotics and probiotics in digestive health. Clin Gastroenterol Hepatol 2019,17(2),333-344","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","volume":"35","author":"Sepideh A.","year":"2016","unstructured":"Sepideh A.; Karim P.; Hossein A.; Leila R.; Hamdollah M.; Mohammad E G.; Mojtaba S.; Mohammad S.; Ghader G.; Seyed Moayed A.; Effects of multistrain probiotic supplementation on glycemic and inflammatory indices in patients with non-alcoholic fatty liver disease: A double-blind randomized clinical trial. J Am Coll Nutr 2016,35(6),500-505","journal-title":"J Am Coll Nutr"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"108455","DOI":"10.1016\/j.lwt.2019.108455","volume":"115","author":"Cai T.","year":"2019","unstructured":"Cai T.; Wu H.; Qin J.; Qiao J.; Yang Y.; Wu Y.; Qiao D.; Xu H.; Cao Y.; In vitro evaluation by PCA and AHP of potential antidiabetic properties of lactic acid bacteria isolated from traditional fermented food. Lebensm Wiss Technol 2019,115,108455","journal-title":"Lebensm Wiss Technol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.11569\/wcjd.v20.i20.1873","volume":"20","author":"Yang L.H.","year":"2012","unstructured":"Yang L.H.; Guo H.; Cai J.; Cai X.W.; Liu G.L.; Chen D.F.; Intervention effect of microbiological capsules containing Bacillus subtilis and Enterococcus on intestinal flora in patients with NASH. World Chin J Dig 2012,20(20),1873","journal-title":"World Chin J Dig"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.chom.2017.11.004","volume":"23","author":"Schroeder B.O.","year":"2018","unstructured":"Schroeder B.O.; Birchenough G.M.H.; St&#xE5;hlman M.; Arike L.; Johansson M.E.V.; Hansson G.C.; B&#xE4;ckhed F.; Bifidobacteria or fiber protects against diet induced microbiota mediated colonic mucus deterioration. Cell Host Microbe 2018,23(1),27-40.e7","journal-title":"Cell Host Microbe"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.maturitas.2018.11.002","volume":"119","author":"Dargahi N.","year":"2019","unstructured":"Dargahi N.; Johnson J.; Donkor O.; Vasiljevic T.; Apostolopoulos V.; Immunomodulatory effects of probiotics: Can they be used to treat allergies and autoimmune diseases? Maturitas 2019,119,25-38","journal-title":"Maturitas"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.3390\/jcm9082648","volume":"9","author":"Di Ciaula A.","year":"2020","unstructured":"Di Ciaula A.; Baj J.; Garruti G.; Celano G.; De Angelis M.; Wang H.H.; Di Palo D.M.; Bonfrate L.; Wang D.Q.; Portincasa P.; Liver steatosis, gut-liver axis, microbiome and environmental factors. A never ending bidirectional cross talk. J Clin Med 2020,9(8),2648","journal-title":"J Clin Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41598-019-56743-x","volume":"10","author":"Ducastel S.","year":"2020","unstructured":"Ducastel S.; Touche V.; Trabelsi M.S.; Boulinguiez A.; Butruille L.; Nawrot M.; Peschard S.; Ch&#xE1;vez T.O.; Dorchies E.; Vallez E.; Annicotte J.S.; Lancel S.; Briand O.; Bantubungi K.; Caron S.; Bindels L.B.; Delzenne N.M.; Tailleux A.; Staels B.; Lestavel S.; The nuclear receptor FXR inhibits glucagon like peptide-1 secretion in response to microbiota derived short chain fatty acids. Sci Rep 2020,10(1),174","journal-title":"Sci Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/jnc.13243","volume":"135","author":"McMillin M.","year":"2015","unstructured":"McMillin M.; Frampton G.; Tobin R.; Dusio G.; Smith J.; Shin H.; Newell R.K.; Grant S.; DeMorrow S.; TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. J Neurochem 2015,135(3),565-576","journal-title":"J Neurochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.apsb.2017.05.005","volume":"7","author":"Rigano D.","year":"2017","unstructured":"Rigano D.; Sirignano C.; Taglialatela S.O.; The potential of natural products for targeting PPAR&#x3B1;. Acta Pharm Sin B 2017,7(4),427-438","journal-title":"Acta Pharm Sin B"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mam.2017.03.002","volume":"56","author":"Merlen G.","year":"2017","unstructured":"Merlen G.; Ursic B.J.; Jourdainne V.; Kahale N.; Glenisson M.; Doignon I.; Rainteau D.; Tordjmann T.; Bile acids and their receptors during liver regeneration: &#x201C;Dangerous protectors&#x201D;. Mol Aspects Med 2017,56,25-33","journal-title":"Mol Aspects Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"Gibson G.R.","year":"2017","unstructured":"Gibson G.R.; Hutkins R.; Sanders M.E.; Prescott S.L.; Reimer R.A.; Salminen S.J.; Scott K.; Stanton C.; Swanson K.S.; Cani P.D.; Verbeke K.; Reid G.; Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017,14(8),491-502","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrgastro.2015.47","volume":"12","author":"Bindels L.B.","year":"2015","unstructured":"Bindels L.B.; Delzenne N.M.; Cani P.D.; Walter J.; Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015,12(5),303-310","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3920\/BM2012.0046","volume":"4","author":"Tsilingiri K.","year":"2013","unstructured":"Tsilingiri K.; Rescigno M.; Postbiotics: What else? Benef Microbes 2013,4(1),101-107","journal-title":"Benef Microbes"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"Levy M.","year":"2017","unstructured":"Levy M.; Kolodziejczyk A.A.; Thaiss C.A.; Elinav E.; Dysbiosis and the immune system. Nat Rev Immunol 2017,17(4),219-232","journal-title":"Nat Rev Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature20796","volume":"540","author":"Thaiss C.A.","year":"2016","unstructured":"Thaiss C.A.; Itav S.; Rothschild D.; Meijer M.T.; Levy M.; Moresi C.; Dohnalov&#xE1; L.; Braverman S.; Rozin S.; Malitsky S.; Dori B.M.; Kuperman Y.; Biton I.; Gertler A.; Harmelin A.; Shapiro H.; Halpern Z.; Aharoni A.; Segal E.; Elinav E.; Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature 2016,540(7634),544-551","journal-title":"Nature"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"Thursby E.","year":"2017","unstructured":"Thursby E.; Juge N.; Introduction to the human gut microbiota. Biochem J 2017,474(11),1823-1836","journal-title":"Biochem J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nut.2012.07.017","volume":"29","author":"Arora T.","year":"2013","unstructured":"Arora T.; Singh S.; Sharma R.K.; Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition 2013,29(4),591-596","journal-title":"Nutrition"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"Hill C.","year":"2014","unstructured":"Hill C.; Guarner F.; Reid G.; Gibson G.R.; Merenstein D.J.; Pot B.; Morelli L.; Canani R.B.; Flint H.J.; Salminen S.; Calder P.C.; Sanders M.E.; Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014,11(8),506-514","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=29","first-page":"558","volume":"28","author":"Soriano G.","year":"2013","unstructured":"Soriano G.; S&#xE1;nchez E.; Guarner C.; Probiotics in liver diseases. Nutr Hosp 2013,28(3),558-563","journal-title":"Nutr Hosp"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","volume":"1","author":"Schwenger K.J.","year":"2019","unstructured":"Schwenger K.J.; Clermont-Dejean N.; Allard J.P.; The role of the gut microbiome in chronic liver disease: The clinical evidence revised. JHEP Rep 2019,1(3),214-226","journal-title":"JHEP Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.idairyj.2015.01.018","volume":"47","author":"Di Lena M.","year":"2015","unstructured":"Di Lena M.; Quero G.M.; Santovito E.; Verran J.; De Angelis M.; Fusco V.; A selective medium for isolation and accurate enumeration of Lactobacillus casei-group members in probiotic milks and dairy products. Int Dairy J 2015,47,27-36","journal-title":"Int Dairy J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biopha.2018.12.104","volume":"111","author":"Kothari D.","year":"2019","unstructured":"Kothari D.; Patel S.; Kim S.K.; Probiotic supplements might not be universally-effective and safe: A review. Biomed Pharmacother 2019,111,537-547","journal-title":"Biomed Pharmacother"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cofs.2020.03.009","volume":"32","author":"Zendeboodi F.","year":"2020","unstructured":"Zendeboodi F.; Khorshidian N.; Mortazavian A.M.; da Cruz A.G.; Probiotic: Conceptualization from a new approach. Curr Opin Food Sci 2020,32,103-123","journal-title":"Curr Opin Food Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"Weiss G.A.","year":"2017","unstructured":"Weiss G.A.; Hennet T.; Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci 2017,74(16),2959-2977","journal-title":"Cell Mol Life Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/imm.12511","volume":"146","author":"Ray A.","year":"2015","unstructured":"Ray A.; Dittel B.N.; Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015,146(3),359-368","journal-title":"Immunology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"Ni J.","year":"2017","unstructured":"Ni J.; Wu G.D.; Albenberg L.; Tomov V.T.; Gut microbiota and IBD: Causation or correlation? Nat Rev Gastroenterol Hepatol 2017,14(10),573-584","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/s41598-021-81871-8","volume":"11","author":"Rackayov&#xE1; V.","year":"2021","unstructured":"Rackayov&#xE1; V.; Flatt E.; Braissant O.; Grosse J.; Capobianco D.; Mastromarino P.; McMillin M.; DeMorrow S.; McLin V.A.; Cudalbu C.; Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease. Sci Rep 2021,11(1),2269","journal-title":"Sci Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/foods9111540","volume":"9","author":"Wang C.","year":"2020","unstructured":"Wang C.; Zhang C.; Li S.; Yu L.; Tian F.; Zhao J.; Zhang H.; Chen W.; Zhai Q.; Effects of probiotic supplementation on dyslipidemia in type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Foods 2020,9(11),1540","journal-title":"Foods"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/ajcn\/71.3.674","volume":"71","author":"St-Onge M.P.","year":"2000","unstructured":"St-Onge M.P.; Farnworth E.R.; Jones P.J.; Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am J Clin Nutr 2000,71(3),674-681","journal-title":"Am J Clin Nutr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2217\/clp.12.40","volume":"7","author":"Zhuang G.","year":"2012","unstructured":"Zhuang G.; Liu X.M.; Zhang Q.X.; Tian F.W.; Zhang H.; Zhang H.P.; Chen W.; Research advances with regards to clinical outcome and potential mechanisms of the cholesterol lowering effects of probiotic. Clin Lipidol 2012,7(5),501-507","journal-title":"Clin Lipidol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e14026","DOI":"10.1111\/jfpp.14026","volume":"43","author":"Gonz&#xE1;lez S.M.","year":"2019","unstructured":"Gonz&#xE1;lez S.M.; Rocha N.E.; Simental L.E.; Rodr&#xED;guez R.; Aguilar C.N.; Rutiaga O.M.; L&#xF3;pez M.G.; Gamboa C.I.; Dehydrated apple\u2010based snack supplemented with Agave fructans exerts prebiotic effect regulating the production of short-chain fatty acid in mice. J Food Process Preserv 2019,43(8),e14026","journal-title":"J Food Process Preserv"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"634780","DOI":"10.3389\/fcimb.2021.634780","volume":"11","author":"Jia X.","year":"2021","unstructured":"Jia X.; Xu W.; Zhang L.; Li X.; Wang R.; Wu S.; Impact of gut microbiota and microbiota related metabolites on hyperlipidemia. Front Cell Infect Microbiol 2021,11,634780","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-017-0183-1","volume":"7","author":"He M.","year":"2017","unstructured":"He M.; Shi B.; Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell Biosci 2017,7(1),54","journal-title":"Cell Biosci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/jam.14678","volume":"129","author":"Lim P.S.","year":"2020","unstructured":"Lim P.S.; Loke C.F.; Ho Y.W.; Tan H.Y.; Cholesterol homeostasis associated with probiotic supplementation in vivo. J Appl Microbiol 2020,129(5),1374-1388","journal-title":"J Appl Microbiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/oby.20428","volume":"21","author":"Yoo S.R.","year":"2013","unstructured":"Yoo S.R.; Kim Y.J.; Park D.Y.; Jung U.J.; Jeon S.M.; Ahn Y.T.; Huh C.S.; McGregor R.; Choi M.S.; Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 2013,21(12),2571-2578","journal-title":"Obesity (Silver Spring)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1017\/S0007114511004491","volume":"107","author":"Chen J.","year":"2012","unstructured":"Chen J.; Wang R.; Li X.F.; Wang R.L.; Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. Br J Nutr 2012,107(10),1429-1434","journal-title":"Br J Nutr"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"103843","DOI":"10.1016\/j.jff.2020.103843","volume":"67","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Wang S.; Zeng Z.; Qin Y.; Shen Q.; Li P.; Antidiabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model. J Funct Foods 2020,67,103843","journal-title":"J Funct Foods"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/gutjnl-2019-319726","volume":"69","author":"Rodriguez J.","year":"2020","unstructured":"Rodriguez J.; Hiel S.; Neyrinck A.M.; Le Roy T.; P&#xF6;tgens S.A.; Leyrolle Q.; Pachikian B.D.; Gianfrancesco M.A.; Cani P.D.; Paquot N.; Cnop M.; Lanthier N.; Thissen J.P.; Bindels L.B.; Delzenne N.M.; Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut 2020,69(11),1975-1987","journal-title":"Gut"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"8601796","DOI":"10.1155\/2020\/8601796","volume":"2020","author":"He Y.J.","year":"2020","unstructured":"He Y.J.; You C.G.; The potential role of gut microbiota in the prevention and treatment of lipid metabolism disorders. Int J Endocrinol 2020,2020,8601796","journal-title":"Int J Endocrinol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"34242","DOI":"10.1038\/srep34242","volume":"6","author":"Leal A.M.","year":"2016","unstructured":"Leal A.M.; Noriega L.G.; Torre I.; Torres N.; Alem&#xE1;n G.; L&#xF3;pez-Romero P.; S&#xE1;nchez M.; Aguilar M.; Furuzawa J.; Vel&#xE1;zquez L.A.; &#xC1;vila A.; Ord&#xE1;z G.; Guti&#xE9;rrez J.A.; Serna S.O.; Tovar A.R.; Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 mice. Sci Rep 2016,6(1),34242","journal-title":"Sci Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/microorganisms7050121","volume":"7","author":"Gupta H.","year":"2019","unstructured":"Gupta H.; Youn G.S.; Shin M.J.; Suk K.T.; Role of gut microbiota in hepatocarcinogenesis. Microorganisms 2019,7(5),121-137","journal-title":"Microorganisms"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"Cani P.D.","year":"2007","unstructured":"Cani P.D.; Amar J.; Iglesias M.A.; Poggi M.; Knauf C.; Bastelica D.; Neyrinck A.M.; Fava F.; Tuohy K.M.; Chabo C.; Waget A.; Delm&#xE9;e E.; Cousin B.; Sulpice T.; Chamontin B.; Ferri&#xE8;res J.; Tanti J.F.; Gibson G.R.; Casteilla L.; Delzenne N.M.; Alessi M.C.; Burcelin R.; Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007,56(7),1761-1772","journal-title":"Diabetes"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1038\/s41598-020-65051-8","volume":"10","author":"Pan X.","year":"2020","unstructured":"Pan X.; Wen S.W.; Kaminga A.C.; Liu A.; Gut metabolites and inflammation factors in non alcoholic fatty liver disease: A systematic review and meta analysis. Sci Rep 2020,10(1),8848","journal-title":"Sci Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e1007954","DOI":"10.1371\/journal.ppat.1007954","volume":"15","author":"Jia B.","year":"2019","unstructured":"Jia B.; Jeon C.O.; Promotion and induction of liver cancer by gut microbiome mediated modulation of bile acids. PLoS Pathog 2019,15(9),e1007954","journal-title":"PLoS Pathog"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.apsb.2019.02.004","volume":"9","author":"Sun L.","year":"2019","unstructured":"Sun L.; Pang Y.; Wang X.; Wu Q.; Liu H.; Liu B.; Liu G.; Ye M.; Kong W.; Jiang C.; Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. Acta Pharm Sin B 2019,9(4),702-710","journal-title":"Acta Pharm Sin B"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1751-7915.13750","volume":"15","author":"Yan R.","year":"2022","unstructured":"Yan R.; Wang K.; Wang Q.; Jiang H.; Lu Y.; Chen X.; Zhang H.; Su X.; Du Y.; Chen L.; Li L.; Lv L.; Probiotic Lactobacillus casei shirota prevents acute liver injury by reshaping the gut microbiota to alleviate excessive inflammation and metabolic disorders. Microb Biotechnol 2022,15(1),247-261","journal-title":"Microb Biotechnol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"110959","DOI":"10.1016\/j.nut.2020.110959","volume":"81","author":"Li M.M.","year":"2021","unstructured":"Li M.M.; Zhou Y.; Zuo L.; Nie D.; Li X.A.; Dietary fiber regulates intestinal flora and suppresses liver and systemic inflammation to alleviate liver fibrosis in mice. Nutrition 2021,81,110959","journal-title":"Nutrition"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12602-020-09663-6","volume":"13","author":"Jantararussamee C.","year":"2021","unstructured":"Jantararussamee C.; Rodniem S.; Taweechotipatr M.; Showpittapornchai U.; Pradidarcheep W.; Hepatoprotective effect of probiotic lactic acid bacteria on thioacetamide induced liver fibrosis in rats. Probiotics Antimicrob Proteins 2021,13(1),40-50","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=59","first-page":"1090","volume":"15","author":"Aller R.","year":"2011","unstructured":"Aller R.; De Luis D.A.; Izaola O.; Conde R.; Gonzalez Sagrado M.; Primo D.; De La Fuente B.; Gonzalez J.; Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: A double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 2011,15(9),1090-1095","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3748\/wjg.v26.i16.1901","volume":"26","author":"Chen H.T.","year":"2020","unstructured":"Chen H.T.; Huang H.L.; Li Y.Q.; Xu H.M.; Zhou Y.J.; Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020,26(16),1901-1911","journal-title":"World J Gastroenterol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13568-020-01038-y","volume":"10","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Liu C.; Zhao S.; Wang X.; Wang J.; Zhang H.; Wang Y.; Zhao G.; Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease. AMB Express 2020,10(1),101","journal-title":"AMB Express"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1111\/1750-3841.15367","volume":"85","author":"Behrouz V.","year":"2020","unstructured":"Behrouz V.; Aryaeian N.; Zahedi M.J.; Jazayeri S.; Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial. J Food Sci 2020,85(10),3611-3617","journal-title":"J Food Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","volume":"57","author":"Malaguarnera M.","year":"2012","unstructured":"Malaguarnera M.; Vacante M.; Antic T.; Giordano M.; Chisari G.; Acquaviva R.; Mastrojeni S.; Malaguarnera G.; Mistretta A.; Li Volti G.; Galvano F.; Bifidobacterium longum with fructooligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 2012,57(2),545-553","journal-title":"Dig Dis Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clnesp.2020.06.020","volume":"39","author":"Abhari K.","year":"2020","unstructured":"Abhari K.; Saadati S.; Yari Z.; Hosseini H.; Hedayati M.; Abhari S.; Alavian S.M.; Hekmatdoost A.; The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. Clin Nutr ESPEN 2020,39,53-60","journal-title":"Clin Nutr ESPEN"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/nu12030632","volume":"12","author":"Neag M.A.","year":"2020","unstructured":"Neag M.A.; Catinean A.; Muntean D.M.; Pop M.R.; Bocsan C.I.; Botan E.C.; Buzoianu A.D.; Probiotic bacillus spores protect against acetaminophen induced acute liver injury in rats. Nutrients 2020,12(3),632","journal-title":"Nutrients"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/nu13010202","volume":"13","author":"Fontana L.","year":"2021","unstructured":"Fontana L.; Plaza J.; Robles P.; Valente H.; S&#xE1;ez M.J.; Abad&#xED;a F.; G&#xF3;mez C.; Gil &#xC1;.; &#xC1;lvarez A.I.; Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 modulate macrophage gene expression and ameliorate damage markers in the liver of Zucker-Leprfa\/fa rats. Nutrients 2021,13(1),202","journal-title":"Nutrients"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jff.2018.08.038","volume":"49","author":"Dargahi N.","year":"2018","unstructured":"Dargahi N.; Johnson J.; Donkor O.; Vasiljevic T.; Apostolopoulos V.; Immunomodulatory effects of Streptococcus thermophilus on U937 monocyte cell cultures. J Funct Foods 2018,49,241-249","journal-title":"J Funct Foods"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1389201022666210104115836","volume":"23","author":"Hajiagha M.N.","year":"2022","unstructured":"Hajiagha M.N.; Taghizadeh S.; Asgharzadeh M.; Dao S.; Ganbarov K.; K&#xF6;se &#x15E;.; Kafil H.S.; Gut microbiota and human body interactions; its impact on health: A review. Curr Pharm Biotechnol 2022,23(1),4-14","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"Pickard J.M.","year":"2017","unstructured":"Pickard J.M.; Zeng M.Y.; Caruso R.; N&#xFA;&#xF1;ez G.; Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 2017,279(1),70-89","journal-title":"Immunol Rev"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00253-015-7049-4","volume":"100","author":"Torres E.","year":"2016","unstructured":"Torres E.; Lenoir M.; Mayorga L.; Allain T.; Sokol H.; Langella P.; S&#xE1;nchez M.E.; Berm&#xFA;dez L.G.; Identification of novel anti-inflammatory probiotic strains isolated from pulque. Appl Microbiol Biotechnol 2016,100(1),385-396","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"Kamada N.","year":"2013","unstructured":"Kamada N.; Seo S.U.; Chen G.Y.; N&#xFA;&#xF1;ez G.; Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013,13(5),321-335","journal-title":"Nat Rev Immunol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.31640\/LS-2013-2-07","volume":"2","author":"Mykhal\u2019chyshyn H.P.","year":"2013","unstructured":"Mykhal\u2019chyshyn H.P.; Bodnar P.M.; Kobyliak N.M.; Effect of probiotics on proinflammatory cytokines level in patients with type 2 diabetes and nonalcoholic fatty liver disease. Lik Sprava 2013,2(2),56-62","journal-title":"Lik Sprava"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1348-0421.2002.tb02765.x","volume":"46","author":"He F.","year":"2002","unstructured":"He F.; Morita H.; Ouwehand A.C.; Hosoda M.; Hiramatsu M.; Kurisaki J.; Isolauri E.; Benno Y.; Salminen S.; Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002,46(11),781-785","journal-title":"Microbiol Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4049\/jimmunol.168.1.171","volume":"168","author":"Christensen H.R.","year":"2002","unstructured":"Christensen H.R.; Fr&#xF8;kiaer H.; Pestka J.J.; Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002,168(1),171-178","journal-title":"J Immunol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2460\/ajvr.67.6.1005","volume":"67","author":"Marshall-Jones Z.V.","year":"2006","unstructured":"Marshall-Jones Z.V.; Baillon M.L.A.; Croft J.M.; Butterwick R.F.; Effects of Lactobacillus acidophilus DSM13241 as a probiotic in healthy adult cats. Am J Vet Res 2006,67(6),1005-1012","journal-title":"Am J Vet Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pbj.2016.03.005","volume":"1","author":"Rouxinol A.L.","year":"2016","unstructured":"Rouxinol A.L.; Pinto A.R.; Janeiro C.; Rodrigues D.; Moreira M.; Dias J.; Pereira P.; Probiotics for the control of obesity - Its effect on weight change. Porto Biomed J 2016,1(1),12-24","journal-title":"Porto Biomed J"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","volume":"11","author":"Winston J.A.","year":"2020","unstructured":"Winston J.A.; Theriot C.M.; Diversification of host bile acids by members of the gut microbiota. Gut Microbes 2020,11(2),158-171","journal-title":"Gut Microbes"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MOL.0000000000000508","volume":"29","author":"de Boer J.F.","year":"2018","unstructured":"de Boer J.F.; Bloks V.W.; Verkade E.; Heiner-Fokkema M.R.; Kuipers F.; New insights in the multiple roles of bile acids and their signaling pathways in metabolic control. Curr Opin Lipidol 2018,29(3),194-202","journal-title":"Curr Opin Lipidol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1128\/JB.188.5.1979-1986.2006","volume":"188","author":"Kurdi P.","year":"2006","unstructured":"Kurdi P.; Kawanishi K.; Mizutani K.; Yokota A.; Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 2006,188(5),1979-1986","journal-title":"J Bacteriol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/joim.12811","volume":"284","author":"Al-Khaifi A.","year":"2018","unstructured":"Al-Khaifi A.; Straniero S.; Voronova V.; Chernikova D.; Sokolov V.; Kumar C.; Angelin B.; Rudling M.; Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism. J Intern Med 2018,284(5),546-559","journal-title":"J Intern Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"9925","DOI":"10.18632\/oncotarget.24066","volume":"9","author":"Yamada S.","year":"2018","unstructured":"Yamada S.; Takashina Y.; Watanabe M.; Nagamine R.; Saito Y.; Kamada N.; Saito H.; Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice. Oncotarget 2018,9(11),9925-9939","journal-title":"Oncotarget"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","volume":"18","author":"Chiang J.Y.L.","year":"2018","unstructured":"Chiang J.Y.L.; Ferrell J.M.; Bile acid metabolism in liver pathobiology. Gene Expr 2018,18(2),71-87","journal-title":"Gene Expr"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fphar.2020.00278","volume":"11","author":"Villette R.","year":"2020","unstructured":"Villette R.; Kc P.; Beliard S.; Salas Tapia M.F.; Rainteau D.; Guerin M.; Lesnik P.; Unraveling host-gut microbiota dialogue and its impact on cholesterol levels. Front Pharmacol 2020,11,278-293","journal-title":"Front Pharmacol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","volume":"9","author":"Li T.","year":"2020","unstructured":"Li T.; Chiang J.Y.L.; Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr 2020,9(2),152-169","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","volume":"1","author":"Chiang J.Y.L.","year":"2017","unstructured":"Chiang J.Y.L.; Bile acid metabolism and signaling in liver disease and therapy. Liver Res 2017,1(1),3-9","journal-title":"Liver Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"Chiang J.Y.L.","year":"2019","unstructured":"Chiang J.Y.L.; Ferrell J.M.; Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr 2019,39(1),175-200","journal-title":"Annu Rev Nutr"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","volume":"66","author":"Li T.","year":"2014","unstructured":"Li T.; Chiang J.Y.L.; Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014,66(4),948-983","journal-title":"Pharmacol Rev"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","volume":"30","author":"Ridlon J.M.","year":"2014","unstructured":"Ridlon J.M.; Kang D.J.; Hylemon P.B.; Bajaj J.S.; Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014,30(3),332-338","journal-title":"Curr Opin Gastroenterol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"Chiang J.Y.L.","year":"2020","unstructured":"Chiang J.Y.L.; Ferrell J.M.; Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol 2020,318(3),G554-G573","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/nu13030713","volume":"13","author":"Alard J.","year":"2021","unstructured":"Alard J.; Cudennec B.; Boutillier D.; Peucelle V.; Descat A.; Decoin R.; Kuylle S.; Jablaoui A.; Rhimi M.; Wolowczuk I.; Pot B.; Tailleux A.; Maguin E.; Holowacz S.; Grangette C.; Multiple selection criteria for probiotic strains with high potential for obesity management. Nutrients 2021,13(3),713","journal-title":"Nutrients"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/nu12061837","volume":"12","author":"Navarro S.L.","year":"2020","unstructured":"Navarro S.L.; Levy L.; Curtis K.R.; Elkon I.; Kahsai O.J.; Ammar H.S.; Randolph T.W.; Hong N.N.; Carnevale Neto F.; Raftery D.; Chapkin R.S.; Lampe J.W.; Hullar M.A.J.; Effect of a flaxseed lignan intervention on circulating bile acids in a placebo-controlled randomized, crossover trial. Nutrients 2020,12(6),1837","journal-title":"Nutrients"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.eng.2020.01.017","volume":"7","author":"Yao M.","year":"2021","unstructured":"Yao M.; Qv L.; Lu Y.; Wang B.; Berglund B.; Li L.; An update on the efficacy and functionality of probiotics for the treatment of non-alcoholic fatty liver disease. Engineering (Beijing) 2021,7(5),679-686","journal-title":"Engineering (Beijing)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"Khovidhunkit W.","year":"2004","unstructured":"Khovidhunkit W.; Kim M.S.; Memon R.A.; Shigenaga J.K.; Moser A.H.; Feingold K.R.; Grunfeld C.; Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J Lipid Res 2004,45(7),1169-1196","journal-title":"J Lipid Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1016\/j.celrep.2020.02.032","volume":"30","author":"Shen Y.","year":"2020","unstructured":"Shen Y.; Su Y.; Silva F.J.; Weller A.H.; Sostre-Col&#xF3;n J.; Titchenell P.M.; Steger D.J.; Seale P.; Soccio R.E.; Shared PPAR&#x3B1;\/&#x3B3; target genes regulate brown adipocyte thermogenic function. Cell Rep 2020,30(9),3079-3091.e5","journal-title":"Cell Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","volume":"54","author":"Staels B.","year":"2005","unstructured":"Staels B.; Fruchart J.C.; Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005,54(8),2460-2470","journal-title":"Diabetes"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"Pawlak M.","year":"2015","unstructured":"Pawlak M.; Lefebvre P.; Staels B.; Molecular mechanism of PPAR&#x3B1; action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol 2015,62(3),720-733","journal-title":"J Hepatol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1128\/MCB.00526-12","volume":"32","author":"Siersb&#xE6;k M.S.","year":"2012","unstructured":"Siersb&#xE6;k M.S.; Loft A.; Aagaard M.M.; Nielsen R.; Schmidt S.F.; Petrovic N.; Nedergaard J.; Mandrup S.; Genome-wide profiling of peroxisome proliferator-activated receptor &#x3B3; in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Mol Cell Biol 2012,32(17),3452-3463","journal-title":"Mol Cell Biol"},{"key":"ref=98","first-page":"101","volume":"57","author":"Wang W.","year":"2018","unstructured":"Wang W.; Shi L.P.; Shi L.; Xu L.; Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease. Zhonghua Nei Ke Za Zhi 2018,57(2),101-106","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1074\/jbc.M605023200","volume":"282","author":"Cha J.Y.","year":"2007","unstructured":"Cha J.Y.; Repa J.J.; The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007,282(1),743-751","journal-title":"J Biol Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"112793","DOI":"10.1016\/j.ejmech.2020.112793","volume":"206","author":"Chen Z.","year":"2020","unstructured":"Chen Z.; Chen H.; Zhang Z.; Ding P.; Yan X.; Li Y.; Zhang S.; Gu Q.; Zhou H.; Xu J.; Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors. Eur J Med Chem 2020,206,112793","journal-title":"Eur J Med Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","volume":"59","author":"Linden A.G.","year":"2018","unstructured":"Linden A.G.; Li S.; Choi H.Y.; Fang F.; Fukasawa M.; Uyeda K.; Hammer R.E.; Horton J.D.; Engelking L.J.; Liang G.; Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J Lipid Res 2018,59(3),475-487","journal-title":"J Lipid Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/nm1102-1243","volume":"8","author":"Repa J.J.","year":"2002","unstructured":"Repa J.J.; Mangelsdorf D.J.; The liver X receptor gene team: Potential new players in atherosclerosis. Nat Med 2002,8(11),1243-1248","journal-title":"Nat Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1126\/science.1168974","volume":"325","author":"Zelcer N.","year":"2009","unstructured":"Zelcer N.; Hong C.; Boyadjian R.; Tontonoz P.; LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009,325(5936),100-104","journal-title":"Science"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4196\/kjpp.2021.25.2.111","volume":"25","author":"Kim B.Y.","year":"2021","unstructured":"Kim B.Y.; Son Y.; Cho H.R.; Lee D.; Eo S.K.; Kim K.; 27-Hydroxycholesterol induces macrophage gene expression via LXR-dependent and -independent mechanisms. Korean J Physiol Pharmacol 2021,25(2),111-118","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","volume":"4","author":"Griffett K.","year":"2015","unstructured":"Griffett K.; Welch R.D.; Flaveny C.A.; Kolar G.R.; Neuschwander-Tetri B.A.; Burris T.P.; The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis. Mol Metab 2015,4(4),353-357","journal-title":"Mol Metab"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"8071093","DOI":"10.1155\/2018\/8071093","volume":"2018","author":"Huang P.","year":"2018","unstructured":"Huang P.; Kaluba B.; Jiang X.L.; Chang S.; Tang X.F.; Mao L.F.; Zhang Z.P.; Huang F.Z.; Liver X receptor inverse agonist SR9243 suppresses non-alcoholic steatohepatitis intrahepatic inflammation and fibrosis. BioMed Res Int 2018,2018,8071093","journal-title":"BioMed Res Int"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.44774","volume":"16","author":"Kumari A.","year":"2020","unstructured":"Kumari A.; Pal Pathak D.; Asthana S.; Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of lipid metabolism. Int J Biol Sci 2020,16(13),2308-2322","journal-title":"Int J Biol Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"e138881","DOI":"10.1172\/jci.insight.138881","volume":"5","author":"Zhou H.","year":"2020","unstructured":"Zhou H.; Zhou S.Y.; Gillilland M.; Li J.Y.; Lee A.; Gao J.; Zhang G.; Xu X.; Owyang C.; Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding. JCI Insight 2020,5(20),e138881","journal-title":"JCI Insight"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","volume":"17","author":"Pineda Torra I.","year":"2003","unstructured":"Pineda Torra I.; Claudel T.; Duval C.; Kosykh V.; Fruchart J.C.; Staels B.; Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol 2003,17(2),259-272","journal-title":"Mol Endocrinol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2017.01.006","volume":"56","author":"Martinot E.","year":"2017","unstructured":"Martinot E.; S&#xE8;des L.; Baptissart M.; Lobaccaro J.M.; Caira F.; Beaudoin C.; Volle D.H.; Bile acids and their receptors. Mol Aspects Med 2017,56,2-9","journal-title":"Mol Aspects Med"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","volume":"33","author":"Kida T.","year":"2013","unstructured":"Kida T.; Tsubosaka Y.; Hori M.; Ozaki H.; Murata T.; Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2013,33(7),1663-1669","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=112","first-page":"25","volume":"19","author":"Pelton R.","year":"2020","unstructured":"Pelton R.; Postbiotic metabolites: How probiotics regulate health. Integr Med (Encinitas) 2020,19(1),25-30","journal-title":"Integr Med (Encinitas)"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tifs.2018.03.009","volume":"75","author":"Aguilar J.E.","year":"2018","unstructured":"Aguilar J.E.; Garcia R.; Garcia H.S.; Mata V.; Gonz&#xE1;lez A.F.; Vallejo B.; Hern&#xE1;ndez A.; Postbiotics: An evolving term within the functional foods field. Trends Food Sci Technol 2018,75,105-114","journal-title":"Trends Food Sci Technol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3390\/ijms23063167","volume":"23","author":"Arellano L.","year":"2022","unstructured":"Arellano L.; Portillo M.P.; Mart&#xED;nez J.A.; Milton I.; Usefulness of probiotics in the management of NAFLD: Evidence and involved mechanisms of action from preclinical and human models. Int J Mol Sci 2022,23(6),3167","journal-title":"Int J Mol Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cofs.2019.12.003","volume":"32","author":"Barros C.P.","year":"2020","unstructured":"Barros C.P.; Guimar&#xE3;es J.T.; Esmerino E.A.; Duarte M.C.K.; Silva M.C.; Silva R.; Ferreira B.M.; Sant\u2019Ana A.S.; Freitas M.Q.; Cruz A.G.; Paraprobiotics and postbiotics: Concepts and potential applications in dairy products. Curr Opin Food Sci 2020,32,1-8","journal-title":"Curr Opin Food Sci"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tifs.2020.12.004","volume":"108","author":"Peluzio M.","year":"2021","unstructured":"Peluzio M.; Martinez J.A.; Milagro F.I.; Postbiotics: Metabolites and mechanisms involved in microbiota-host interactions. Trends Food Sci Technol 2021,108,11-26","journal-title":"Trends Food Sci Technol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13679-020-00379-w","volume":"9","author":"Vallianou N.","year":"2020","unstructured":"Vallianou N.; Stratigou T.; Christodoulatos G.S.; Tsigalou C.; Dalamaga M.; Probiotics, prebiotics, synbiotics, postbiotics, and obesity: Current evidence, controversies, and perspectives. Curr Obes Rep 2020,9(3),179-192","journal-title":"Curr Obes Rep"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3746\/pnf.2020.25.2.113","volume":"25","author":"Aoun A.","year":"2020","unstructured":"Aoun A.; Darwish F.; Hamod N.; The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss. Prev Nutr Food Sci 2020,25(2),113-123","journal-title":"Prev Nutr Food Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/nu13093211","volume":"13","author":"Li H.Y.","year":"2021","unstructured":"Li H.Y.; Zhou D.D.; Gan R.Y.; Huang S.Y.; Zhao C.N.; Shang A.; Xu X.Y.; Li H.B.; Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients 2021,13(9),3211","journal-title":"Nutrients"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","volume":"23","author":"Zhou D.","year":"2017","unstructured":"Zhou D.; Pan Q.; Xin F.Z.; Zhang R.N.; He C.X.; Chen G.Y.; Liu C.; Chen Y.W.; Fan J.G.; Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol 2017,23(1),60-75","journal-title":"World J Gastroenterol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3389\/fmicb.2018.01967","volume":"9","author":"Ye J.","year":"2018","unstructured":"Ye J.; Lv L.; Wu W.; Li Y.; Shi D.; Fang D.; Guo F.; Jiang H.; Yan R.; Ye W.; Li L.; Butyrate protects mice against methioninecholine-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front Microbiol 2018,9,1967","journal-title":"Front Microbiol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/molecules26020472","volume":"26","author":"Osman A.","year":"2021","unstructured":"Osman A.; El-Gazzar N.; Almanaa T.N.; El-Hadary A.; Sitohy M.; Lipolytic postbiotic from Lactobacillus paracasei manages metabolic syndrome in albino Wistar rats. Molecules 2021,26(2),472","journal-title":"Molecules"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1021\/acs.jafc.5b05827","volume":"64","author":"Nakamura F.","year":"2016","unstructured":"Nakamura F.; Ishida Y.; Sawada D.; Ashida N.; Sugawara T.; Sakai M.; Goto T.; Kawada T.; Fujiwara S.; Fragmented lactic acid bacterial cells activate peroxisome proliferator-activated receptors and ameliorate dyslipidemia in obese mice. J Agric Food Chem 2016,64(12),2549-2559","journal-title":"J Agric Food Chem"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220818145350","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207646\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220818145350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T02:58:18Z","timestamp":1727837898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207646\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201023666220818145350","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}